NCT04085744

Brief Summary

This study aims to compare effects of two different agents on complications due to tracheal tube cuff in pediatric patients. Sore throat, hoarseness, laryngospasm, bronchospasm are the main complications.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
91

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 7, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 11, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2019

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2020

Completed
Last Updated

November 18, 2023

Status Verified

November 1, 2023

Enrollment Period

8 months

First QC Date

September 7, 2019

Last Update Submit

November 17, 2023

Conditions

Keywords

intubationanesthesiacorticosteroidslidocainecomplication of intubation

Outcome Measures

Primary Outcomes (4)

  • Visual analog scale (VAS) for pain

    Self Reported VAS at postoperative unit. VAS 0 is no pain VAS 10 is pain as bad as can be

    1 hour

  • Visual analog scale (VAS) for pain

    Self reported VAS postoperative at hour 6. VAS 0 is no pain VAS 10 is pain as bad as can be

    6 hours

  • Visual analog scale (VAS) for pain

    Self reported VAS postoperative at hour 12. VAS 0 is no pain VAS 10 is pain as bad as can be

    12 hours

  • Visual analog scale (VAS) for pain

    Self reported VAS at postoperative hour 24. VAS 0 is no pain VAS 10 is pain as bad as can be

    24 hours

Study Arms (3)

control group

NO INTERVENTION

In this group any drug will be applied on the cuff of the intubation tube

lidocaine group

ACTIVE COMPARATOR

10% lidocaine spray will be applied on the cuff of the intubation tube topically and patient will be intubated.

Drug: Lidocaine 10% Spray

steroid group

ACTIVE COMPARATOR

mometasone furoate spray will be applied on the cuff of the intubation tube topically and patient will be intubated.

Drug: Mometasone nasal spray

Interventions

lidocaine will be apply on the cuff

Also known as: lidocaine
lidocaine group

mometasone spray will be applied on the cuff

Also known as: steroid
steroid group

Eligibility Criteria

Age2 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Being ages between 2 and 18
  • undergoing elective surgery
  • intubated patients over 1 hour
  • ASA(American Society of Anesthesiologists) Class I-II patients

You may not qualify if:

  • Urgent surgeries
  • Tonsillectomies, adenoidectomies ..etc, operations that causes sore throat due to the operation area.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Health and Science University Derince Training and Research Hospital

Derince, Kocaeli, 41900, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pharyngitis

Interventions

LidocaineSteroids

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsPharyngeal DiseasesStomatognathic DiseasesRespiratory Tract DiseasesOtorhinolaryngologic Diseases

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesFused-Ring CompoundsPolycyclic Compounds

Study Officials

  • Ayse Z Turan

    HEALTH AND SCİENCE UNIVERSITY DERINCE TRAINING AND RESEARCH HOSPITAL

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 7, 2019

First Posted

September 11, 2019

Study Start

November 1, 2019

Primary Completion

June 15, 2020

Study Completion

June 15, 2020

Last Updated

November 18, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations